BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37756564)

  • 1. Long-Read Sequencing Reveals Alternative Splicing-Driven, Shared Immunogenic Neoepitopes Regardless of SF3B1 Status in Uveal Melanoma.
    Yao T; Zhang Z; Li Q; Huang R; Hong Y; Li C; Zhang F; Huang Y; Fang Y; Cao Q; Jin X; Li C; Wang Z; Lin XJ; Li L; Wei W; Wang Z; Shen J
    Cancer Immunol Res; 2023 Dec; 11(12):1671-1687. PubMed ID: 37756564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing Patterns in
    Bigot J; Lalanne AI; Lucibello F; Gueguen P; Houy A; Dayot S; Ganier O; Gilet J; Tosello J; Nemati F; Pierron G; Waterfall JJ; Barnhill R; Gardrat S; Piperno-Neumann S; Popova T; Masson V; Loew D; Mariani P; Cassoux N; Amigorena S; Rodrigues M; Alsafadi S; Stern MH; Lantz O
    Cancer Discov; 2021 Aug; 11(8):1938-1951. PubMed ID: 33811047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spliceosome Mutations in Uveal Melanoma.
    Nguyen JQN; Drabarek W; Yavuzyigitoglu S; Medico Salsench E; Verdijk RM; Naus NC; de Klein A; Kiliç E; Brosens E
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal Melanoma in Chinese Patients.
    Hou C; Xiao L; Ren X; Tang F; Guo B; Zeng W; Liang C; Yan N
    Ophthalmic Res; 2020; 63(3):358-368. PubMed ID: 31614358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SF3B1 mutations are associated with alternative splicing in uveal melanoma.
    Furney SJ; Pedersen M; Gentien D; Dumont AG; Rapinat A; Desjardins L; Turajlic S; Piperno-Neumann S; de la Grange P; Roman-Roman S; Stern MH; Marais R
    Cancer Discov; 2013 Oct; 3(10):1122-1129. PubMed ID: 23861464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.
    Yavuzyigitoglu S; Koopmans AE; Verdijk RM; Vaarwater J; Eussen B; van Bodegom A; Paridaens D; Kiliç E; de Klein A;
    Ophthalmology; 2016 May; 123(5):1118-28. PubMed ID: 26923342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening of drugs that selectively inhibit uveal melanoma cells with SF3B1 mutations].
    Luo X; Ren C; Liu X; Zhang G; Huang S; Yu L; Li Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1835-1842. PubMed ID: 35012916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
    Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
    JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing reveals the likely involvement of SOX10 in uveal melanoma.
    Das D; Kaur I; Ali MJ; Biswas NK; Das S; Kumar S; Honavar SG; Maitra A; Chakrabarti S; Majumder PP
    Optom Vis Sci; 2014 Jul; 91(7):e185-92. PubMed ID: 24927141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence.
    Yu L; Zhou D; Zhang G; Ren Z; Luo X; Liu P; Plouffe SW; Meng Z; Moroishi T; Li Y; Zhang Y; Brown JH; Liu S; Guan KL
    Mol Oncol; 2022 Feb; 16(3):607-629. PubMed ID: 34706158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal rearrangements in uveal melanoma: Chromothripsis.
    van Poppelen NM; Yavuzyigitoglu S; Smit KN; Vaarwater J; Eussen B; Brands T; Paridaens D; Kiliç E; de Klein A
    Genes Chromosomes Cancer; 2018 Sep; 57(9):452-458. PubMed ID: 29726589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF
    Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Profiling of Metastatic Uveal Melanoma Shows Frequent Coexisting BAP1 or SF3B1 and GNAQ/GNA11 Mutations and Correlation With Prognosis.
    Isaacson AL; Sompallae RR; Guseva NV; Bellizzi AM; Bossler AD; Ma D
    Am J Clin Pathol; 2022 Aug; 158(2):177-186. PubMed ID: 35212356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.
    Harbour JW; Roberson ED; Anbunathan H; Onken MD; Worley LA; Bowcock AM
    Nat Genet; 2013 Feb; 45(2):133-5. PubMed ID: 23313955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.
    Royer-Bertrand B; Torsello M; Rimoldi D; El Zaoui I; Cisarova K; Pescini-Gobert R; Raynaud F; Zografos L; Schalenbourg A; Speiser D; Nicolas M; Vallat L; Klein R; Leyvraz S; Ciriello G; Riggi N; Moulin AP; Rivolta C
    Am J Hum Genet; 2016 Nov; 99(5):1190-1198. PubMed ID: 27745836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
    Wan Q; Sang X; Jin L; Wang Z
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
    Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
    Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage.
    Alsafadi S; Houy A; Battistella A; Popova T; Wassef M; Henry E; Tirode F; Constantinou A; Piperno-Neumann S; Roman-Roman S; Dutertre M; Stern MH
    Nat Commun; 2016 Feb; 7():10615. PubMed ID: 26842708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients.
    Lee WS; Lee J; Choi JJ; Kang HG; Lee SC; Kim JH
    Sci Rep; 2021 Sep; 11(1):18594. PubMed ID: 34545149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation.
    Szalai E; Jiang Y; van Poppelen NM; Jager MJ; de Klein A; Kilic E; Grossniklaus HE
    JAMA Ophthalmol; 2018 Oct; 136(10):1115-1120. PubMed ID: 30073324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.